Roche to Acquire PathAI to Expand AI-Powered Digital Pathology
May 7, 2026
Roche has entered into a definitive merger agreement to acquire PathAI, a US digital pathology and AI technology company. The deal is expected to close in the second half of the year and will integrate PathAI’s AISight image management system into Roche’s Diagnostics division.
- Buyers
- Roche
- Targets
- PathAI
- Industry
- AI & Machine Learning
- Location
- United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.